This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!
Drug Lovastatin Shows Big Drop in Cholesterol
A study of 356 222 men aged 35 to 57 from 1973 to 1979 ties high cholesterol to elevated heart attack risk. Merck reports lovastatin reduced cholesterol by 32 percent in 18 weeks, with potential to cut fatal heart attack risk as FDA review proceeds.
MENTIONED IN THIS ARTICLE
Chicago
Journal of the American Medical Association
Jeremiah Stamler
Stamler
Northwestern University Medical School
Merck Sharp & Dohme
Basil Rifkind
National Heart, Lung and Blood Institute
Bethesda
Rifkind
Marvin E. Jaffe
West Point
Merck
U.S. Food and Drug Administration